Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Phase I study of capecitabine, oxaliplatin, bevacizumab, and everolimus in advanced solid tumors.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Phase I study of capecitabine, oxaliplatin, bevacizumab, and everolimus in advanced solid tumors.
Phase I study of capecitabine, oxaliplatin, bevacizumab, and everolimus in advanced solid tumors. Invest New Drugs. 2014 Aug; 32(4):700-9.
View in:
PubMed
subject areas
Angiogenesis Inhibitors
Antibodies, Monoclonal, Humanized
Antimetabolites, Antineoplastic
Antineoplastic Agents
Antineoplastic Combined Chemotherapy Protocols
Bevacizumab
Biomarkers, Tumor
Capecitabine
Deoxycytidine
Everolimus
Female
Fluorouracil
Humans
Immunosuppressive Agents
Male
Maximum Tolerated Dose
Middle Aged
Neoplasms
Neuropilin-1
Neuropilin-2
Organoplatinum Compounds
RNA, Messenger
Sirolimus
Vascular Endothelial Growth Factor A
authors with profiles
Mark Kozloff